A comprehensive analysis on The Cancer Genome Atlas (TCGA) data from hundreds of patients with papillary thyroid carcinoma underscored the significance of PGC1α downregulation, as it correlated with a higher disease stage and an increased risk of recurrence (17). The gene discussed is PPARGC1A; the disease is thyroid gland papillary carcinoma.